CYP2R1 | Cytochrome P450, family 2, subfamily R, polypeptide 1 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
CYP2S1 | Cytochrome P450, family 2, subfamily S, polypeptide 1 | Enzymes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CYP2U1 | Cytochrome P450, family 2, subfamily U, polypeptide 1 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Mixed |
CYP3A4 | Cytochrome P450, family 3, subfamily A, polypeptide 4 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CYP3A43 | Cytochrome P450, family 3, subfamily A, polypeptide 43 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
CYP46A1 | Cytochrome P450, family 46, subfamily A, polypeptide 1 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
CYP4B1 | Cytochrome P450, family 4, subfamily B, polypeptide 1 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CYP4F11 | Cytochrome P450, family 4, subfamily F, polypeptide 11 | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CYP4F2 | Cytochrome P450, family 4, subfamily F, polypeptide 2 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CYP4F3 | Cytochrome P450, family 4, subfamily F, polypeptide 3 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CYP4F8 | Cytochrome P450, family 4, subfamily F, polypeptide 8 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CYP4V2 | Cytochrome P450, family 4, subfamily V, polypeptide 2 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Mixed |
CYP4X1 | Cytochrome P450, family 4, subfamily X, polypeptide 1 | Enzymes Predicted membrane proteins
| | | | | Mixed |
CYP4Z1 | Cytochrome P450, family 4, subfamily Z, polypeptide 1 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
CYP51A1 | Cytochrome P450, family 51, subfamily A, polypeptide 1 | Enzymes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CYP7B1 | Cytochrome P450, family 7, subfamily B, polypeptide 1 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Mixed |
DAO | D-amino-acid oxidase | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
DBH | Dopamine beta-hydroxylase (dopamine beta-monooxygenase) | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
DCXR | Dicarbonyl/L-xylulose reductase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
DDO | D-aspartate oxidase | Enzymes Predicted membrane proteins
| | | | | Mixed |
DECR1 | 2,4-dienoyl CoA reductase 1, mitochondrial | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
DECR2 | 2,4-dienoyl CoA reductase 2, peroxisomal | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
DHCR24 | 24-dehydrocholesterol reductase | Cytoskeleton related proteins Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
DHCR7 | 7-dehydrocholesterol reductase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
DHDH | Dihydrodiol dehydrogenase (dimeric) | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
DHFR | Dihydrofolate reductase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Mixed |
DHFRL1 | Dihydrofolate reductase-like 1 | Enzymes Predicted intracellular proteins
| | | | | Mixed |
DHODH | Dihydroorotate dehydrogenase (quinone) | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
DHRS3 | Dehydrogenase/reductase (SDR family) member 3 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
DHRS4 | Dehydrogenase/reductase (SDR family) member 4 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
DHTKD1 | Dehydrogenase E1 and transketolase domain containing 1 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
DIO1 | Deiodinase, iodothyronine, type I | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
DIO2 | Deiodinase, iodothyronine, type II | Enzymes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
DLD | Dihydrolipoamide dehydrogenase | Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
DMGDH | Dimethylglycine dehydrogenase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
DOHH | Deoxyhypusine hydroxylase/monooxygenase | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
DPYD | Dihydropyrimidine dehydrogenase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
DUOX1 | Dual oxidase 1 | Enzymes Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
EGLN1 | Egl-9 family hypoxia-inducible factor 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
EGLN2 | Egl-9 family hypoxia-inducible factor 2 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
EGLN3 | Egl-9 family hypoxia-inducible factor 3 | Enzymes Predicted intracellular proteins
| | | | | Mixed |
EHHADH | Enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
EPX | Eosinophil peroxidase | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
ETFDH | Electron-transferring-flavoprotein dehydrogenase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ETHE1 | Ethylmalonic encephalopathy 1 | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
FAM213B | Family with sequence similarity 213, member B | Enzymes Predicted intracellular proteins
| | | | | Mixed |
FAR1 | Fatty acyl CoA reductase 1 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
FAR2 | Fatty acyl CoA reductase 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
FASN | Fatty acid synthase | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
FDXR | Ferredoxin reductase | Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enhanced |